Cargando…
Design, Recombinant Fusion Expression and Biological Evaluation of Vasoactive Intestinal Peptide Analogue as Novel Antimicrobial Agent
Antimicrobial peptides represent an emerging category of therapeutic agents with remarkable structural and functional diversity. Modified vasoactive intestinal peptide (VIP) (VIP analogue 8 with amino acid sequence “FTANYTRLRRQLAVRRYLAAILGRR”) without haemolytic activity and cytotoxicity displayed e...
Autores principales: | Xu, Chunlan, Guo, Yu, Qiao, Xiangjin, Shang, Xiaoya, Niu, Weining, Jin, Mingliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150413/ https://www.ncbi.nlm.nih.gov/pubmed/29135962 http://dx.doi.org/10.3390/molecules22111963 |
Ejemplares similares
-
Modulatory Effects of Vasoactive Intestinal Peptide on Intestinal Mucosal Immunity and Microbial Community of Weaned Piglets Challenged by an Enterotoxigenic Escherichia coli (K88)
por: Xu, Chunlan, et al.
Publicado: (2014) -
Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats
por: Xu, Chun-Lan, et al.
Publicado: (2018) -
Effect of Vitamin E Supplementation on Intestinal Barrier Function in Rats Exposed to High Altitude Hypoxia Environment
por: Xu, Chunlan, et al.
Publicado: (2014) -
Role of vasoactive intestinal peptide in osteoarthritis
por: Jiang, Wei, et al.
Publicado: (2016) -
F-18 Labeled Vasoactive Intestinal Peptide Analogue in the PET Imaging of Colon Carcinoma in Nude Mice
por: Cheng, Dengfeng, et al.
Publicado: (2013)